Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Supplementary Treatment With Agaricus Blazei Based Mushroom Extract, Andosan, on Patients With Asthma and Allergy

NCT05192720 is registered in ClinicalTrials.gov with University Hospital, Akershus as lead sponsor.

NCT NCT05192720
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05192720 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Supplementary Treatment With Agaricus Blazei Based Mushroom Extract, Andosan, on Patients With Asthma and Allergy
Lead sponsor
University Hospital, Akershus
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2021
Completion date
February 28, 2023
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic asthma, allergic rhinoconjunctivitis, immune tolerance